Lower Trapezius Transfer vs Bridging Reconstruction
Launched by NOVA SCOTIA HEALTH AUTHORITY · Jun 22, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to compare two different surgical techniques for treating large, severe rotator cuff tears that cannot be repaired in the usual way. The two methods being studied are bridging reconstruction, which uses a special graft to help support the shoulder, and lower trapezius tendon transfer, which involves moving a nearby muscle tendon to help restore shoulder function. Researchers want to find out which method leads to better shoulder movement, strength, and overall quality of life for patients.
To participate, individuals must be between 18 and 74 years old and have a confirmed diagnosis of a massive rotator cuff tear larger than 5 cm. Other important criteria include having no more than 50% muscle loss and not having certain shoulder or health conditions that could complicate the surgery. Participants will be randomly assigned to one of the two surgical groups and will be monitored for at least two years to see how well each method works. If you or a loved one is considering participating, this study could help provide valuable insights into the best treatment options for severe rotator cuff injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • magnetic resonance imaging (MRI) proven diagnosis of a massive rotator cuff tear
- • tear size \>5cm
- • two-tendon, irreparable tear
- • competent adult (\>18 years of age)
- • \<50% muscle atrophy.
- Exclusion Criteria:
- • irreparable subscapular tear
- • glenohumeral osteoarthritis
- • WORC score \> 70
- • uncontrolled diabetes (Hgb A1C \>7%)
- • pregnancy
- • presence of local or systemic infection
- • inability to cooperate with and/or comprehend post-operative instructions
- • cancer
- • paralysis of the shoulder
- • contracture of the shoulder
- • inability to provide informed consent
About Nova Scotia Health Authority
The Nova Scotia Health Authority (NSHA) is a leading healthcare organization dedicated to enhancing the health and well-being of individuals and communities across Nova Scotia, Canada. As the largest provider of health services in the province, NSHA is committed to advancing clinical research and innovation through rigorous clinical trials that aim to improve patient care and outcomes. With a focus on collaboration, NSHA engages healthcare professionals, researchers, and patients to address pressing health challenges and contribute to the global body of medical knowledge. By fostering a culture of evidence-based practice and continual improvement, NSHA plays a pivotal role in shaping the future of healthcare delivery in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Halifax, Nova Scotia, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported